LURBINECTEDIN EEUU : LAS VENTAS EN EL 1er SEMESTRE 25 HAN SIDO DE 137,5 MILL$ // SE HAN REDUCIDO UN 12% QUE SON 18,6 MILL$ MENOS Vs A LAS ALCANZADAS EN EL MISMO PERIODO DE 2024 QUE FUERON DE 156,1 MILL$ // VENTAS DE TARLATAMAB EN.EL 2o TRIM 25 HAN ALCANZADO LOS 134 MILL$ ... UN 65% MÁS ... VERSUS LOS 61 MILL$ QUE ALCANZÓ EN EL 1er TRIM25 // TARLA 1er SEMESTRE 25 = VENTAS DE 215 MILL$ ... QUE SON 77,8 MILL$ MÁS QUE LOS ALCANZADOS POR LURBI (137,5 MILL$) EN EL MISMO PERIODO
26 enero 2009
Pfizer could pay $68 billion for Wyeth .
An agreement between the drug makers might be announced Monday. It would be the largest acquisition in five years for the industry.
Bloomberg
January 26, 2009
New York -- Pfizer Inc. would pay about $68 billion to acquire Wyeth in a bid reviewed Sunday by boards for the two drug companies, according to people familiar with the talks.
Bloomberg
January 26, 2009
New York -- Pfizer Inc. would pay about $68 billion to acquire Wyeth in a bid reviewed Sunday by boards for the two drug companies, according to people familiar with the talks.
Suscribirse a:
Entradas (Atom)